MedPath

Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertensio

Not Applicable
Conditions
Atrial Fibrillation with hypertension
Registration Number
JPRN-UMIN000046613
Lead Sponsor
Cardiology University Northern Yokohama Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are intolerant for ARNI Patients with renal insufficiency (estimated GFR < 30) Patients with systolic blood pressure <100 mmHg When the attending physician consider inappropriate to enroll the patient in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath